HGH 191AA (Somatropin）H12 12iu*10vials

HGH 191AA H12 12iu x 10 Vials

Product Overview

HGH 191AA H12 is a high-activity fully recombinant human growth hormone in the H-series research portfolio, representing an enhanced product upgraded from the H8 and H10 formulas. Composed of 191 complete amino acids, it supports natural human growth hormone structural homology research, retaining biological activity, growth hormone receptor affinity, and downstream signal transduction capability research characteristics. Utilizing advanced high-purity recombinant expression and precision vacuum freeze-drying technology, H12 12iu supports specific activity enhancement and maximum pathway activation amplitude research, demonstrating anabolic and metabolic remodeling effects research capabilities compared to traditional 8iu and 10iu specifications. As a high-standard high-dose exogenous growth hormone direct supplement, it supports endogenous pituitary function dependence elimination research, achieving high-amplitude linear dose controllable growth hormone and insulin-like growth factor-1 axis upregulation research. Designed for strong anabolic metabolism research, deep systemic metabolic remodeling research, high-load tissue damage repair research, anti-aging endocrine intervention research, and high-standard peptide synergistic effects validation research, this product serves as a core reference substance for high-threshold growth hormone pharmacological mechanism research and gradient-based preclinical efficacy studies.

Core Research Functions

JAK2/STAT5 Downstream Signaling Pathway Activation: Supports GH and IGF-1 downstream JAK2/STAT5 signaling pathway full activation research, somatic cell proliferation comprehensive enhancement, high-density lean muscle fiber synthesis, systemic visceral and subcutaneous fat decomposition and metabolism, and high-level basal metabolic regulation studies.

Lean Muscle Hypertrophy and High-Load Damage Repair: Supports strong lean muscle hypertrophy research and high-load damage repair studies.

Visceral Fat Decomposition and Deep Metabolic Remodeling: Supports thorough visceral fat decomposition research and deep metabolic remodeling studies, and basal metabolic rate maximization research.

Cellular Senescence Inhibition: Supports cellular senescence significant inhibition research and high-standard high-intensity somatic cell growth regulation studies.

Body Composition Optimization Mechanism Exploration: Supports high-intensity body composition optimization mechanism exploration research and complex peptide stacking validation studies.

Compared to the balanced efficacy of H8 and the standard high-efficiency H10, 12iu of H12 achieves comprehensive enhancement in core physiological phenotypes, exhibiting superior advantages in core research dimensions. Unlike endogenous pulsatile growth hormone-releasing hormone peptides that depend on pituitary responses, exogenous 191AA H12 supports precise high-dose linear growth hormone supplementation research, supporting individual endogenous response differences and experimental signal attenuation avoidance research. This ensures stable significant phenotypic output under long-term high-intensity intervention research. The 12iu high specification supports high potency and research safety balance research, suitable for high-dose gradient threshold screening, long-term extreme metabolic intervention modeling, high-intensity body composition optimization mechanism exploration, and complex peptide stacking validation, providing saturated maximum amplitude high-discrimination reproducible data for high-threshold growth hormone pharmacology, extreme metabolic regulation, and advanced anti-aging physiology in-depth research.

Core Product Advantages

191AA All-Natural Homologous High-Activity Structure: The complete full-length human growth hormone amino acid sequence, supporting fragment truncation and structural mutations related studies. Its molecular conformation supports natural human growth hormone identity research, receptor binding activity, and physiological simulation realism research, exceeding modified peptides and fragment peptide products in biological activity research.

12iu High-Potency Upper Limit Specification: The single-vial dose exceeds the mainstream 8iu and 10iu specifications, achieving the performance upper limit of the H-series in terms of growth hormone axis activation and systemic anabolism intensity. It supports traditional specification insufficient intervention effect related problem research, meeting high-threshold research needs, providing research capabilities that exceed lower gradient specification efficacy ranges.

Precise Linear High-Dose Exogenous Supplementation: Supports downstream metabolic and anabolism pathways independent activation research, without relying on endogenous secretion from the hypothalamus-pituitary axis. It supports linear dose-response relationship and controllability research, providing significant experimental phenotypes and supporting high-precision pharmacological mechanism research.

Pharmaceutical-Grade High-Purity Quality Control: Employing upgraded multi-stage purification and fully locked vacuum freeze-drying processes, preserving protein activity with stable specific activity and minimal foreign proteins and invalid fragments, providing high-purity experimental variables and supporting accurate reproducible research conclusions.

Advanced Standard Aseptic Integrated Packaging: 10 vials per box in aseptic integrated packaging. Each batch undergoes rigorous HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term stable activity maintenance, it is suitable for advanced laboratory research, key scientific research projects, and customized bulk procurement.

Specifications and Quality Control

Format: Lyophilized powder, 12iu per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).